| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison.
|
Lancet
|
2002
|
4.21
|
|
2
|
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.
|
Arch Intern Med
|
2002
|
3.96
|
|
3
|
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial.
|
Lancet
|
2008
|
3.73
|
|
4
|
Continued sports activity, using a pain-monitoring model, during rehabilitation in patients with Achilles tendinopathy: a randomized controlled study.
|
Am J Sports Med
|
2007
|
2.31
|
|
5
|
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial.
|
Lancet
|
2002
|
2.26
|
|
6
|
Acute achilles tendon rupture: a randomized, controlled study comparing surgical and nonsurgical treatments using validated outcome measures.
|
Am J Sports Med
|
2010
|
2.07
|
|
7
|
Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis.
|
Thromb Haemost
|
2009
|
1.76
|
|
8
|
Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement.
|
Thromb Haemost
|
2008
|
1.64
|
|
9
|
Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement.
|
J Clin Pharmacol
|
2005
|
1.58
|
|
10
|
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery.
|
Thromb Haemost
|
2010
|
1.47
|
|
11
|
The Achilles tendon Total Rupture Score (ATRS): development and validation.
|
Am J Sports Med
|
2006
|
1.46
|
|
12
|
Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.
|
Blood
|
2005
|
1.43
|
|
13
|
Dabigatran etexilate.
|
Nat Rev Drug Discov
|
2008
|
1.41
|
|
14
|
Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery.
|
Clin Pharmacokinet
|
2008
|
1.39
|
|
15
|
Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies.
|
Thromb Haemost
|
2010
|
1.39
|
|
16
|
Major functional deficits persist 2 years after acute Achilles tendon rupture.
|
Knee Surg Sports Traumatol Arthrosc
|
2011
|
1.15
|
|
17
|
Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
|
Thromb Haemost
|
2010
|
1.14
|
|
18
|
Fondaparinux, the first selective factor Xa inhibitor.
|
Curr Opin Hematol
|
2003
|
1.06
|
|
19
|
Kinematics and laxity of the knee joint after anterior cruciate ligament reconstruction: pre- and postoperative radiostereometric studies.
|
Am J Sports Med
|
2002
|
1.05
|
|
20
|
Traffic flow in the operating room: an explorative and descriptive study on air quality during orthopedic trauma implant surgery.
|
Am J Infect Control
|
2012
|
1.04
|
|
21
|
A new measurement of heel-rise endurance with the ability to detect functional deficits in patients with Achilles tendon rupture.
|
Knee Surg Sports Traumatol Arthrosc
|
2009
|
1.01
|
|
22
|
Stable surgical repair with accelerated rehabilitation versus nonsurgical treatment for acute Achilles tendon ruptures: a randomized controlled study.
|
Am J Sports Med
|
2013
|
1.01
|
|
23
|
Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis.
|
Br J Clin Pharmacol
|
2006
|
1.01
|
|
24
|
Thromboprophylaxis in patients older than 75 years or with moderate renal impairment undergoing knee or hip replacement surgery [corrected].
|
Int Orthop
|
2011
|
0.98
|
|
25
|
Biodegradable and metallic interference screws in anterior cruciate ligament reconstruction surgery using hamstring tendon grafts: prospective randomized study of radiographic results and clinical outcome.
|
Am J Sports Med
|
2006
|
0.93
|
|
26
|
Full symptomatic recovery does not ensure full recovery of muscle-tendon function in patients with Achilles tendinopathy.
|
Br J Sports Med
|
2007
|
0.91
|
|
27
|
High incidence of deep venous thrombosis after Achilles tendon rupture: a prospective study.
|
Knee Surg Sports Traumatol Arthrosc
|
2009
|
0.91
|
|
28
|
The application of evidence-based measures to reduce surgical site infections during orthopedic surgery - report of a single-center experience in Sweden.
|
Patient Saf Surg
|
2012
|
0.89
|
|
29
|
Treatment of distal tibial fractures with the Ilizarov external fixator--a prospective observational study in 39 consecutive patients.
|
BMC Musculoskelet Disord
|
2013
|
0.89
|
|
30
|
Early active extension after anterior cruciate ligament reconstruction does not result in increased laxity of the knee.
|
Knee Surg Sports Traumatol Arthrosc
|
2006
|
0.89
|
|
31
|
Determinants of self-efficacy in the rehabilitation of patients with anterior cruciate ligament injury.
|
J Rehabil Med
|
2007
|
0.87
|
|
32
|
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
|
Thromb Haemost
|
2007
|
0.87
|
|
33
|
A new surgical method to treat chronic ruptures and reruptures of the Achilles tendon.
|
Knee Surg Sports Traumatol Arthrosc
|
2008
|
0.83
|
|
34
|
Detection of slow-cycling and stem/progenitor cells in different regions of rat Achilles tendon: response to treadmill exercise.
|
Knee Surg Sports Traumatol Arthrosc
|
2013
|
0.82
|
|
35
|
Pharmacokinetics of melagatran and the effect on ex vivo coagulation time in orthopaedic surgery patients receiving subcutaneous melagatran and oral ximelagatran: a population model analysis.
|
Clin Pharmacokinet
|
2003
|
0.82
|
|
36
|
Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty.
|
Pathophysiol Haemost Thromb
|
2006
|
0.81
|
|
37
|
New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies.
|
Chest
|
2003
|
0.80
|
|
38
|
Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points.
|
Chest
|
2004
|
0.80
|
|
39
|
Antihirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery: incidence and clinical relevance.
|
Blood
|
2002
|
0.79
|
|
40
|
Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials.
|
Thromb J
|
2012
|
0.79
|
|
41
|
Ilizarov external fixation or locked intramedullary nailing in diaphyseal tibial fractures: a randomized, prospective study of 58 consecutive patients.
|
Arch Orthop Trauma Surg
|
2014
|
0.79
|
|
42
|
KT-1000 records smaller side-to-side differences than radiostereometric analysis before and after an ACL reconstruction.
|
Knee Surg Sports Traumatol Arthrosc
|
2006
|
0.79
|
|
43
|
Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
|
Best Pract Res Clin Haematol
|
2013
|
0.78
|
|
44
|
The Ilizarov external fixator--a useful alternative for the treatment of proximal tibial fractures. A prospective observational study of 30 consecutive patients.
|
BMC Musculoskelet Disord
|
2013
|
0.78
|
|
45
|
Will early reconstruction prevent abnormal kinematics after ACL injury? Two-year follow-up using dynamic radiostereometry in 14 patients operated with hamstring autografts.
|
Knee Surg Sports Traumatol Arthrosc
|
2011
|
0.77
|
|
46
|
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.
|
Clin Orthop Relat Res
|
2008
|
0.77
|
|
47
|
Significantly lower need for blood transfusions associated with post-operatively initiated subcutaneous melagatran/oral ximelagatran compared with enoxaparin.
|
Thromb Haemost
|
2004
|
0.77
|
|
48
|
Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding.
|
Thromb Haemost
|
2012
|
0.77
|
|
49
|
Postoperative Melagatran/Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery : Effects of Timing of First Dose and Risk Factors for Thromboembolism and Bleeding Complications on Efficacy and Safety.
|
Clin Drug Investig
|
2005
|
0.76
|
|
50
|
A randomized, controlled study of a rehabilitation model to improve knee-function self-efficacy with ACL injury.
|
J Sport Rehabil
|
2010
|
0.76
|
|
51
|
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
|
Lancet
|
2003
|
0.75
|
|
52
|
A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery.
|
J South Orthop Assoc
|
2002
|
0.75
|
|
53
|
A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialist.
|
J South Orthop Assoc
|
2002
|
0.75
|
|
54
|
Hand Contamination, Cross-Transmission, and Risk-Associated Behaviors: An Observational Study of Team Members in ORs.
|
AORN J
|
2015
|
0.75
|
|
55
|
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism.
|
Curr Opin Pulm Med
|
2002
|
0.75
|
|
56
|
[Self-belief--basis for successful rehabilitation. Confidence in one's own ability a strong predictor in orthopedic injury].
|
Lakartidningen
|
2009
|
0.75
|
|
57
|
Fondaparinux.
|
J Am Acad Orthop Surg
|
2004
|
0.75
|